John Schmid in

John Schmid

Examiner · DISC type sc
Board Member and Audit Chair at Bright Peak Therapeutics
📍 Rancho Santa Fe, California, United States

John is a results-oriented CFO and Board Member in the life sciences industry with over 35 years of experience, specializing in financing the development and commercialization of therapeutic products. Colleagues describe him as "tenacious" and "high energy. " He holds an MBA from the University of San Diego and a BA from Wesleyan University.

Beyond his extensive work in biotech, John is the financial founder and Chairman of Speak, Inc. , the largest speakers bureau in the western U. S. , which he helped establish in 1989. This demonstrates a long-standing interest in public speaking and communication alongside his financial career.

He was named the 2021 Director of the Year for "Companies in Transition" by the Corporate Directors Forum.

Read the full overview →
Experience
36 Years
Current Role
Board Member and Audit Chair
Location
Rancho Santa Fe, California, United States
Personality Overview

How John shows up

Process Oriented
Unexpressive
Status Quo Seeker

Being observant comes to them naturally. They are heavily focused on quality and prefer doing things the right way, even if it takes time. They are thorough and always follow a systematic approach.

Priorities

Topics John cares about

Biotech Financing
As a CFO, he has raised over $900 million through private and public equity, including taking two companies public himself and serving on the board for six other IPOs.
Corporate Governance
He serves as Audit Chair and a board member for multiple public biotech companies, including Bright Peak Therapeutics, Design Therapeutics, and AnaptysBio, and was named Director of the Year.
+4 more topics Login to view topics
Career

Work history

3-2025
Board Member and Audit Chair
Bright Peak Therapeutics
11-2020
Board Member, Audit Committee Chair and Compensation Committee Member
Design Therapeutics (Nasdaq: DSGN)
6-2015
Board Member, Audit Committee Chair and Compensation Committee Member
AnaptysBio (Nasdaq: ANAB)
6-1989
Chairman
Speak, Inc.
2-2024 - 8-2025
Board Member and Audit Chair
Helix Acquisiton Corp. II (Nasdaq: HLXB)
In the press

Media appearances

Bright Peak Therapeutics Appoints John Schmid to its Board of Directors. Featured in GlobeNewswire
See now
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors. Featured in Bright Peak Therapeutics
+1 more appearances Login to view media
Education
1981 - 1985
Bachelors
Wesleyan University
1990 - 1992
MBA
University of San Diego
Social presence
in
Behavioral profile

DISC profile (public)

s

Steadiness (S)

Steadiness (S) reflects the degree to which a person is likely to focus on cooperation, support and taking everyone along. Those scoring high tend to be consistent and calm.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to John. Free, 10 seconds.